PPT-Differentiating Among the CDK 4/6 Inhibitors in the Management of Metastatic Breast Cancer

This program will include a discussion of offlabel treatment and investigational agents not approved by the FDA for use in the United States and data that were presented in abstract form These data should be considered preliminary until published in a peerreviewed journal. CDK 4/6 Inhibitors in Breast Cancer Expert Perspectives on New Data Faculty Javier Cortes, MD, PhD Head Breast Cancer Program Oncology Department Ramon y Cajal University Hospital Madrid, Spain Targeting endocrine-resistance pathways in breast cancer Clara Natoli, Chieti Endocrine responsive breast cancer Luminal A High expression of ER & ER-related genes Lower An Interactive Oncology Grand Rounds Series. Joyce O’Shaughnessy, MD. Chair, Breast Cancer Research Program. Baylor Charles A Sammons Cancer Center. Celebrating Women Chair in Breast Cancer Research. Julie R. Gralow, M.D.. Director, Breast Medical Oncology. Jill Bennett Endowed Professor of Breast Cancer. Professor, Global Health. University of Washington School of Medicine. Fred Hutchinson Cancer Research Center. VeruInc Oncology Biopharmaceutical Company Focused on Prostate Cancer and Breast CancerVeru Corporate PresentationJefferies Virtual Healthcare ConferenceJune 1 June 4 2021Forward looking statements2Th www.nature.com/articles/nrd4504 (2015). https. ://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345933. /. http://. science.sciencemag.org/content/345/6199/865.full. Mol . Cancer . Ther. . 15. . 2273-2281 (2016). Breast Cancer : How important is it? . It is the most common cancer among women in lower-and-middle-income in Asian countries. . Its cost to society in terms of . - use of healthcare resources . Most of these lesions are benign. Breast cancer is 2. nd. most common cause of cancer deaths in women, following. carcinoma of the lung. . The clinical significance of the . benign. conditions:. 1- possible clinical confusion with malignancy. ProductInformation HOPC. Mrs GV is a 78 year old women who presented to Cabrini ED with acute dyspnoea is the setting of recent malignant pleural effusion in the setting of Metastatic Breast Ca.. Nov 2010: Self Detected left breast lump (AJCC Stage . March 2019. Preview/Introduction. The Risk of Breast Cancer to Women. Does Mammography Save Lives?. When to Start and How Often Should Women Screen?. Risks Versus Benefits of Mammography. Breast Cancer: The Impact on Women. Azeez Farooki, MD. Attending Physician, Clinical Member. Memorial Sloan Kettering Cancer Center. New York, NY. Objectives. Elucidate the problem of aromatase inhibitor induced bone loss and increased risk of fractures in breast cancer. Background of lower back pain for 3/12 . No past medical Hx.. Social Hx: . Married 2 small children, works in hospital admin. Regular Menstrual periods. Family Hx: . Aunt: Breast Ca 55. Aims. O/E:. Palpable LN under the right axilla. Key recommendations. 1. National and local workforce planning is essential. Health Education England and all Cancer Alliances should urgently ensure there are enough healthcare professionals to deliver high-quality and timely diagnosis, treatment and care to local women..